Marikki Peltoniemi

Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment

M. Airaksinen, M. Kekäle, Marikki Peltoniemi, 2015, Patient preference and adherence.

Permeability and toxicity characteristics of L-cysteine and 2-methyl-thiazolidine-4-carboxylic acid in Caco-2 cells

M. Schmitt, Kirsi Harju, Alma Kartal-Hodzic, 2013, Pharmaceutical development and technology.

Computational prediction of local drug effect on carcinogenic acetaldehyde in the mouth based on in vitro/in vivo results of freely soluble l-cysteine

M. Sivén, Marikki Peltoniemi, A. Kartal, 2010, Drug development and industrial pharmacy.

Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs

O. Vainio, M. Heinonen, M. Raekallio, 2012, Acta Veterinaria Scandinavica.

Spray-dried amorphous isomalt and melibiose, two potential protein-stabilizing excipients.

H. Räikkönen, A. Juppo, T. Lipiäinen, 2016, International journal of pharmaceutics.

Formulation and stability of cytokine therapeutics.

A. Urtti, A. Juppo, H. Vuorela, 2015, Journal of pharmaceutical sciences.

Comparison of melibiose and trehalose as stabilising excipients for spray‐dried &bgr;‐galactosidase formulations

Heikki Räikkönen, Anne Juppo, H. Räikkönen, 2018, International journal of pharmaceutics.

Determinants of New Product Launch Success in the Pharmaceutical Industry

P. Parvinen, T. Rajalahti, A. Juppo, 2015, Journal of Pharmaceutical Innovation.

The role of active transport in the transcellular movement of the peripheral α2-adrenoceptor antagonist, MK-467: An in vitro pilot study.

M. Scheinin, O. Vainio, M. Raekallio, 2017, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.